Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)

被引:1
|
作者
Autio, Karen A.
Anand, Aseem
Krupa, Rachel
Louw, Jessica
Arslan, Zaina
Dittamore, Ryan
Scher, Howard I.
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Epic Sci Inc, La Jolla, CA USA
关键词
D O I
10.1200/jco.2014.32.4_suppl.198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
198
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Expression of prostate-specific membrane antigen (PSMA) on circulating tumor cells (CTCs) in castration-resistant prostate cancer.
    Lee, Florence
    Yu, Angela
    Anderson, Amanda
    Marrinucci, Dena
    Magargal, Wells W.
    DiPippo, Vincent A.
    Olson, William C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [2] The expression of prostate-specific membrane antigen in circulating tumor cells (CTC) of castration-resistant prostate cancer: The association with poor treatment response
    Nagaya, N.
    Kanayama, M.
    Nagata, M.
    Horie, S.
    ANNALS OF ONCOLOGY, 2017, 28 : 78 - 78
  • [3] The change in expression of prostate-specific membrane antigen in circulating tumor cells during treatments for castration-resistant prostate cancer
    Nagaya, N.
    Kanayama, M.
    Nagata, M.
    Horie, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Baseline and post-treatment circulating tumor cell (CTC) counts with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Sun, Michael
    Lebenthal, Justin M.
    Nauseef, Jones T.
    Niaz, Muhammad Junaid
    Guervil, Sabrina
    Fernandez, Escarleth
    Patel, Amie
    Tan, Angela
    Vlachostergios, Panagiotis J.
    Osborne, Joseph
    Molina, Ana M.
    Sternberg, Cora N.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [5] Prostate-specific membrane antigen (PSMA) in circulating tumor cells (CTCS) is a new poor prognostic marker for castration-resistant prostate cancer (CRPC)
    Nagata, M.
    Nagaya, N.
    Horie, S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 33 - 34
  • [6] Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
    Nagaya, Naoya
    Nagata, Masayoshi
    Lu, Yan
    Kanayama, Mayuko
    Hou, Qi
    Hotta, Zen-u
    China, Toshiyuki
    Kitamura, Kosuke
    Matsushita, Kazuhito
    Isotani, Shuji
    Muto, Satoru
    Sakamoto, Yoshiro
    Horie, Shigeo
    PLOS ONE, 2020, 15 (01):
  • [7] Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
    Vlachostergios, Panagiotis J.
    Niaz, Muhammad Junaid
    Sun, Michael
    Mosallaie, Seyed Ali
    Thomas, Charlene
    Christos, Paul J.
    Osborne, Joseph R.
    Molina, Ana M.
    Nanus, David M.
    Bander, Neil H.
    Tagawa, Scott T.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Clinical and molecular features of low prostate-specific membrane antigen (PSMA) expression in patients (pts) with metastatic castration resistant prostate cancer (mCRPC).
    de Kouchkovsky, Ivan
    Zhang, Li
    Huang, Jiaoti
    Trepka, Kai
    Chou, Jonathan
    Foye, Adam
    Shui, David
    Wong, Chris
    Friedl, Verena
    Weinstein, Alana
    Hope, Thomas A.
    Quigley, David A.
    Stuart, Josh
    Beer, Tomasz M.
    Reiter, Robert Evan
    Gleave, Martin E.
    Evans, Christopher P.
    Feng, Felix Y.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] Circulating tumour cells (CTC) count and prostate-specific antigen (PSA) response measures in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with docetaxel (Doc)
    Lozano Mejorada, R.
    Lorente, D.
    Castro, E.
    Bianchini, D.
    Nombela, P.
    Sandhu, S. K.
    Romero Laorden, N.
    Cendon, Y.
    Sharp, A.
    Almagro Casado, E.
    Pacheco, M. I.
    Rescigno, P.
    Llacer, C.
    Saez, M.
    Rivera, L.
    Vitrone, F.
    Moreno, C.
    Mateo, J.
    de Bono, J. S.
    Olmos Hidalgo, D.
    ANNALS OF ONCOLOGY, 2019, 30 : 350 - 350
  • [10] Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
    Teo, Min Yuen
    Morris, Michael J.
    CANCER JOURNAL, 2016, 22 (05): : 347 - 352